Skip to main content

Risk prediction for Staphylococcus aureus surgical site infection following cardiothoracic surgery; A secondary analysis of the V710-P003 trial.

Publication ,  Journal Article
Paling, FP; Olsen, K; Ohneberg, K; Wolkewitz, M; Fowler, VG; DiNubile, MJ; Jafri, HS; Sifakis, F; Bonten, MJM; Harbarth, SJ; Kluytmans, JAJW
Published in: PLoS One
2018

BACKGROUND: Identifying patients undergoing cardiothoracic surgery at high risk of Staphylococcus aureus surgical site infection (SSI) is a prerequisite for implementing effective preventive interventions. The objective of this study was to develop a risk prediction model for S. aureus SSI or bacteremia after cardiothoracic surgery based on pre-operative variables. MATERIALS/METHODS: Data from the Merck Phase IIb/III S. aureus vaccine (V710-P003) clinical trial were analyzed. In this randomized placebo-controlled trial, the effect of preoperative vaccination against S. aureus was investigated in patients undergoing cardiothoracic surgery. The primary outcome was deep/superficial S. aureus SSI or S. aureus bacteremia through day 90 after surgery. Performance, calibration, and discrimination of the final model were assessed. RESULTS: Overall 164 out of 7,647 included patients (2.1%) developed S. aureus infection (149 SSI, 15 bacteremia, 28 both). Independent risk factors for developing the primary outcome were pre-operative colonization with S. aureus (OR 3.08, 95% confidence interval [CI] 2.23-4.22), diabetes mellitus (OR 1.87, 95% CI 1.34-2.60), BMI (OR 1.02 per kg/m2, 95% CI 0.99-1.05), and CABG (OR 2.67, 95% CI 1.91-3.78). Although vaccination had a significant (albeit modest) protective effect, it was omitted from the model because its addition did not significantly change the coefficients of the final model and V710-vaccine development has been discontinued due to insufficient efficacy. The final prediction model had moderate discriminative accuracy (AUC-value, 0.72). CONCLUSION: Pre-operative S. aureus colonization status, diabetes mellitus, BMI, and type of surgical procedure moderately predicted the risk of S. aureus SSI and/or bacteremia among patients undergoing cardiothoracic surgery.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

PLoS One

DOI

EISSN

1932-6203

Publication Date

2018

Volume

13

Issue

3

Start / End Page

e0193445

Location

United States

Related Subject Headings

  • Vaccination
  • Surgical Wound Infection
  • Staphylococcus aureus
  • Staphylococcal Vaccines
  • Staphylococcal Infections
  • Risk Factors
  • Prospective Studies
  • Middle Aged
  • Male
  • Humans
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Paling, F. P., Olsen, K., Ohneberg, K., Wolkewitz, M., Fowler, V. G., DiNubile, M. J., … Kluytmans, J. A. J. W. (2018). Risk prediction for Staphylococcus aureus surgical site infection following cardiothoracic surgery; A secondary analysis of the V710-P003 trial. PLoS One, 13(3), e0193445. https://doi.org/10.1371/journal.pone.0193445
Paling, Fleur P., Karina Olsen, Kristin Ohneberg, Martin Wolkewitz, Vance G. Fowler, Mark J. DiNubile, Hasan S. Jafri, et al. “Risk prediction for Staphylococcus aureus surgical site infection following cardiothoracic surgery; A secondary analysis of the V710-P003 trial.PLoS One 13, no. 3 (2018): e0193445. https://doi.org/10.1371/journal.pone.0193445.
Paling FP, Olsen K, Ohneberg K, Wolkewitz M, Fowler VG, DiNubile MJ, et al. Risk prediction for Staphylococcus aureus surgical site infection following cardiothoracic surgery; A secondary analysis of the V710-P003 trial. PLoS One. 2018;13(3):e0193445.
Paling, Fleur P., et al. “Risk prediction for Staphylococcus aureus surgical site infection following cardiothoracic surgery; A secondary analysis of the V710-P003 trial.PLoS One, vol. 13, no. 3, 2018, p. e0193445. Pubmed, doi:10.1371/journal.pone.0193445.
Paling FP, Olsen K, Ohneberg K, Wolkewitz M, Fowler VG, DiNubile MJ, Jafri HS, Sifakis F, Bonten MJM, Harbarth SJ, Kluytmans JAJW. Risk prediction for Staphylococcus aureus surgical site infection following cardiothoracic surgery; A secondary analysis of the V710-P003 trial. PLoS One. 2018;13(3):e0193445.

Published In

PLoS One

DOI

EISSN

1932-6203

Publication Date

2018

Volume

13

Issue

3

Start / End Page

e0193445

Location

United States

Related Subject Headings

  • Vaccination
  • Surgical Wound Infection
  • Staphylococcus aureus
  • Staphylococcal Vaccines
  • Staphylococcal Infections
  • Risk Factors
  • Prospective Studies
  • Middle Aged
  • Male
  • Humans